Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ramundo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Endocrinological Investigation|July 16, 2011
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard dosesP Ferolla, A Faggiano, F Grimaldi, et al.
Minerva Endocrinologica|November 29, 2013
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1M Del Prete, V Marotta, V Ramundo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2012
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative studyA Faggiano, V Ramundo, A P Assanti, et al.
Journal of the American Geriatrics Society|September 5, 2007
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patientsStefano Spiezia, Roberto Garberoglio, Carolina Di Somma, et al.
Journal of Cellular and Molecular Medicine|September 3, 2011
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro studyA Faggiano, V Ramundo, A Dicitore, et al.
Clinical Endocrinology|January 22, 2014
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumoursV Ramundo, M Del Prete, V Marotta, et al.
ESMO Open|November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)F Spada, F Gelsomino, M Rinzivillo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Endocrinological Investigation|July 16, 2011
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard dosesP Ferolla, A Faggiano, F Grimaldi, et al.
Minerva Endocrinologica|November 29, 2013
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1M Del Prete, V Marotta, V Ramundo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2012
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative studyA Faggiano, V Ramundo, A P Assanti, et al.
Journal of the American Geriatrics Society|September 5, 2007
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patientsStefano Spiezia, Roberto Garberoglio, Carolina Di Somma, et al.
Journal of Cellular and Molecular Medicine|September 3, 2011
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro studyA Faggiano, V Ramundo, A Dicitore, et al.
Clinical Endocrinology|January 22, 2014
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumoursV Ramundo, M Del Prete, V Marotta, et al.
ESMO Open|November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)F Spada, F Gelsomino, M Rinzivillo, et al.
Pageof 2